190 related articles for article (PubMed ID: 353599)
1. Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07.
Humble MW; Bettelheim KA
N Z Med J; 1978 May; 87(612):366. PubMed ID: 353599
[No Abstract] [Full Text] [Related]
2. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
Skalova R; Hajsig D; Babić I; Mostovac D
Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
[No Abstract] [Full Text] [Related]
4. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
Knothe H; Krcméry V; Mitsuhashi S
Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
Strausbaugh LJ; Mandaleris CD; Sande MA
J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713
[TBL] [Abstract][Full Text] [Related]
6. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
[No Abstract] [Full Text] [Related]
7. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
[TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli].
Nicoletti G; Russo G; Toscano MA; Gismondo MR
Boll Ist Sieroter Milan; 1979 Jan; 57(6):713-7. PubMed ID: 121911
[TBL] [Abstract][Full Text] [Related]
9. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
Drasar FA; Farrell W; Maskell J; Williams JD
Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
[TBL] [Abstract][Full Text] [Related]
10. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage.
Knothe H; Lebek G; Krcméry V; Seginková Z; Cervenka J; Antal M; Mitsuhashi S
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):506-10. PubMed ID: 6800151
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
Block CS; Fabian B; Robinson RG
S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
[TBL] [Abstract][Full Text] [Related]
12. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
Al-Asadi MJ; Towner K; Greenwood D
J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
[TBL] [Abstract][Full Text] [Related]
13. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
Juhlin I; Tunevall G
Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
15. Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.
Seligman SJ
Antimicrob Agents Chemother; 1978 Jan; 13(1):70-3. PubMed ID: 626492
[TBL] [Abstract][Full Text] [Related]
16. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
[No Abstract] [Full Text] [Related]
17. Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.
Ruiz J; Bertran S; Sauca G; Julià A; Vila X; Gómez E; Jiménez de Anta MT; Vila J
Clin Microbiol Infect; 2005 Jan; 11(1):71-3. PubMed ID: 15649309
[TBL] [Abstract][Full Text] [Related]
18. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
[TBL] [Abstract][Full Text] [Related]
19. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
Moellering RC; Wennersten C; Kunz LJ; Poitras JW
Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
[TBL] [Abstract][Full Text] [Related]
20. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
Jotzoff M
Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]